Meeting
2014 ASCO Annual Meeting
Characterization of the mTOR autophosphorylation site, S2481, as a novel biomarker in renal cell carcinoma (RCC).
Authors
Lauren Christine Harshman
Dana-Farber Cancer Institute, Boston, MA
Lauren Christine Harshman , Karra Muller , Chii-Dean Lin , James D. Brooks , John Higgins , Jon Berglin , Tony Hunter , Jeremy Copp
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer
Sub Track
Kidney Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 4571)
DOI
10.1200/jco.2014.32.15_suppl.4571
Abstract #
4571
Poster Bd #
139
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Predictive factors for recurrence and outcomes in T1a renal cell carcinoma: Analysis of the INMARC (International Marker Consortium for Renal Cancer) database.
First Author: Franklin Liu
Poster
2023 ASCO Genitourinary Cancers Symposium
Real world outcomes of patients with non-clear cell renal cell carcinoma: A single Asian centre experience.
First Author: Johan W.K. Chan
Poster
2020 Genitourinary Cancers Symposium
NF2 mutation-driven renal cell carcinomas (RCC): A comprehensive genomic profiling (CGP) study.
First Author: Evgeny Yakirevich
Poster
2016 Genitourinary Cancers Symposium
Prognostic utility of a multi-gene signature (the cell cycle proliferation score) in patients with renal cell carcinoma (RCC) after radical nephrectomy.
First Author: Todd Matthew Morgan